Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Name: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices
Brand: Springer
SKU: 9781461288886
Price: 20022.00 INR
Availability: InStock

Proceedings of the Ninth Annual Symposium on New Drugs & Devices

by J. Morganroth

Springer · 2011 · Paperback

₹20,022

Free delivery. Nothing extra to pay at checkout.

Same Day ShippingIn 3–5 days

15-Day ReturnEasy returns

Genuine BookPhysical copy only

Available Offers

🏷️Use code GIG9, pay ₹19,522 — save ₹500 (up to ₹500 off per order)
💵Cash on Delivery — pay when the parcel reaches you

About this book

Published by Springer in 2011, Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices by J.